![5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide](https://static.cymitquimica.com/products/3D/img/DAC58484.png "Cliquez pour agrandir")
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide
CAS : 1253584-84-7
Ref. 3D-DAC58484
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide
Description :
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide (JNJ-635) is a small molecule inhibitor of the endocannabinoid metabolism. It prevents the degradation of anandamide and 2-arachidonoylglycerol (2AG). JNJ-635 has been shown to have antiinflammatory properties in vitro and in vivo, as well as anticonvulsant effects in mice. In addition, JNJ-635 has demonstrated neuroprotective effects in models of Alzheimer's disease and nonconvulsive seizures. These effects are mediated by the inhibition of microglial activation, which leads to reduced production of proinflammatory cytokines such as IL1β.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
454.44 g/mol
Formule :
C22H22N4O7
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
